Despite its functions against some pro-oncogenic pathways in untransformed cells18, we have shown that aberrant expression and activity of GSK3β in tumors sustains tumor cell survival and proliferation as well as invasion and therapy resistance in gastrointestinal and pancreatic cancer, glioblastoma and bone and soft tissue sarcomas. Here, GSK3B is linked to neoplasm.